High-precision conformal radiotherapy (HPCRT) of prostate cancer--a new technique for exact positioning of the prostate at the time of treatment.

PURPOSE Biopsies taken 2 years after radiotherapy of localized prostate cancer indicate residual tumor cells in 20-60% of cases, and the prognosis for these patients is unfavorable. More precise methods of localization of the prostate are desirable to increase the dose to the prostate tumor and minimize the volume of adjacent sensitive tissues that are currently included in the planning target volume. We have sought a method to more accurately locate the prostate at the time of treatment, allowing a reduction of the volume of rectum and bladder included in the high dose region during dose escalation. METHODS AND RESULTS We have developed a new technique using a special urethral catheter (patent pending), containing markers that can be visualized by the radiotherapy machine for accurate positioning of the prostate. The catheter is used throughout the treatment planning procedure and the isocenter is placed on one of the markers. On the treatment couch the markers are visualized on port-films and with portal imaging immediately before dose delivery. A beam-center-marker on the accelerator makes it possible to adjust the isocenter position to within 1 mm, giving very high precision, independent of external fixation. The technique involves a simple patient setup. The method has been tested in five patients with conventional dose level (70 Gy) and in 24 patients in the first Scandinavian dose escalation study with external beam radiotherapy. No increase in acute side-effects was observed. CONCLUSION With the new high precision conformal radiotherapy (HPCRT) technique we have developed a technique that allows us to increase the dose to the prostate without excessive side effects. The method reduces the uncertainties in prostate localization, is easy to handle, and feasible in routine treatment.

[1]  E. Crawford,et al.  Advanced prostate cancer , 1999, Prostate Cancer and Prostatic Diseases.

[2]  C. Perez,et al.  Tumor control in definitive irradiation of localized carcinoma of the prostate. , 1986, International journal of radiation oncology, biology, physics.

[3]  K Lam,et al.  Measurement of prostate movement over the course of routine radiotherapy using implanted markers. , 1995, International journal of radiation oncology, biology, physics.

[4]  A. Zietman,et al.  Radical prostatectomy and radical radiation therapy for clinical stages T1 to 2 adenocarcinoma of the prostate: new insights into outcome from repeat biopsy and prostate specific antigen followup. , 1994, The Journal of urology.

[5]  M. Zelefsky,et al.  Three-dimensional conformal radiation therapy in localized carcinoma of the prostate: interim report of a phase 1 dose-escalation study. , 1994, The Journal of urology.

[6]  T. Stamey,et al.  Identification of residual cancer in the prostate following radiation therapy: role of transrectal ultrasound guided biopsy and prostate specific antigen. , 1989, The Journal of urology.

[7]  P. Scardino,et al.  Local control of prostate cancer with radiotherapy: frequency and prognostic significance of positive results of postirradiation prostate biopsy. , 1988, NCI monographs : a publication of the National Cancer Institute.

[8]  K. Russell,et al.  Fast Neutron Radiotherapy for Locally Advanced Prostate Cancer: Final Report of a Radiation Therapy Oncology Group Randomized Clinical Trial , 1993, American journal of clinical oncology.

[9]  D L McShan,et al.  Boost treatment of the prostate using shaped, fixed fields. , 1989, International journal of radiation oncology, biology, physics.

[10]  C B Begg,et al.  The effect of local control on metastatic dissemination in carcinoma of the prostate: long-term results in patients treated with 125I implantation. , 1991, International journal of radiation oncology, biology, physics.

[11]  H. Sandler,et al.  Three dimensional conformal radiotherapy for the treatment of prostate cancer: low risk of chronic rectal morbidity observed in a large series of patients. , 1995, International journal of radiation oncology, biology, physics.

[12]  C. Perez,et al.  Factors influencing outcome of definitive radiotherapy for localized carcinoma of the prostate. , 1989, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[13]  L. Verhey,et al.  The value of nonuniform margins for six-field conformal irradiation of localized prostate cancer. , 1995, International journal of radiation oncology, biology, physics.

[14]  G J Kutcher,et al.  Variation in prostate position quantitation and implications for three-dimensional conformal treatment planning. , 1997, International journal of radiation oncology, biology, physics.

[15]  L. Holmberg,et al.  Transrectal ultrasonically-guided core biopsies in the assessment of local cure of prostatic cancer after radical external beam radiotherapy. , 1995, Acta oncologica.

[16]  H. Sandler,et al.  Dose escalation for stage C (T3) prostate cancer: minimal rectal toxicity observed using conformal therapy. , 1992, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[17]  G T Chen,et al.  Online repositioning during treatment of the prostate: a study of potential limits and gains. , 1993, International journal of radiation oncology, biology, physics.

[18]  K L Lam,et al.  Automated localization of the prostate at the time of treatment using implanted radiopaque markers: technical feasibility. , 1995, International journal of radiation oncology, biology, physics.

[19]  H. Sandler,et al.  Potential improvement in the results of irradiation for prostate carcinoma using improved dose distribution. , 1992, International journal of radiation oncology, biology, physics.

[20]  L. Verhey,et al.  Advanced prostate cancer: the results of a randomized comparative trial of high dose irradiation boosting with conformal protons compared with conventional dose irradiation using photons alone. , 1995, International journal of radiation oncology, biology, physics.

[21]  H. Sandler,et al.  3D conformal radiotherapy for the treatment of prostate cancer: Low risk of chronic rectal morbidity observed in a large series of patients , 1993 .

[22]  M. Norberg,et al.  Characterization of localized prostatic cancer: distribution, grading and pT-staging in radical prostatectomy specimens. , 1993, Scandinavian journal of urology and nephrology.

[23]  K. Russell,et al.  Photon versus fast neutron external beam radiotherapy in the treatment of locally advanced prostate cancer: results of a randomized prospective trial. , 1994, International journal of radiation oncology, biology, physics.

[24]  R. Henriksson,et al.  Daily-diary evaluated side-effects of conformal versus conventional prostatic cancer radiotherapy technique. , 1997, Acta oncologica.

[25]  P Wootton,et al.  Impact of a multileaf collimator on treatment morbidity in localized carcinoma of the prostate. , 1994, International journal of radiation oncology, biology, physics.

[26]  T E Schultheiss,et al.  Conformal technique dose escalation for prostate cancer: biochemical evidence of improved cancer control with higher doses in patients with pretreatment prostate-specific antigen > or = 10 NG/ML. , 1996, International journal of radiation oncology, biology, physics.

[27]  R. Gittes Carcinoma of the prostate. , 1991, The New England journal of medicine.

[28]  A. Zietman,et al.  Use of PSA nadir to predict subsequent biochemical outcome following external beam radiation therapy for T1-2 adenocarcinoma of the prostate. , 1996, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[29]  T E Schultheiss,et al.  Lateral rectal shielding reduces late rectal morbidity following high dose three-dimensional conformal radiation therapy for clinically localized prostate cancer: further evidence for a significant dose effect. , 1996, International journal of radiation oncology, biology, physics.

[30]  R. Abrams,et al.  Androgen deprivation with radiation therapy compared with radiation therapy alone for locally advanced prostatic carcinoma: a randomized comparative trial of the Radiation Therapy Oncology Group. , 1995, Urology.

[31]  T. Schultheiss,et al.  Factors influencing incidence of acute grade ii morbidity in conformal and standard radiation treatment of prostate cancer: univariate and multivariate analysis , 1993 .

[32]  C. Orton,et al.  Hyperfractionated conformal radiotherapy in locally advanced prostate cancer: results of a dose escalation study. , 1996, International journal of radiation oncology, biology, physics.

[33]  G E Hanks,et al.  The effect of dose on local control of prostate cancer. , 1988, International journal of radiation oncology, biology, physics.

[34]  F. Freiha,et al.  Carcinoma of the prostate: Results of post‐irradiation biopsy , 1984, The Prostate.

[35]  H M Sandler,et al.  Localization of the prostatic apex for radiation therapy using implanted markers. , 1993, International journal of radiation oncology, biology, physics.

[36]  T. Schultheiss,et al.  Incidence of and factors related to late complications in conformal and conventional radiation treatment of cancer of the prostate. , 1995, International journal of radiation oncology, biology, physics.

[37]  M. Roach,et al.  Radiotherapy for high grade clinically localized adenocarcinoma of the prostate. , 1996, The Journal of urology.